Login to Your Account

With no end in sight for chemo drugs, Oasmia focuses on formulation

By Marie Powers
News Editor

Monday, January 25, 2016

Executives at Oasmia Pharmaceutical AB came to the J.P. Morgan Healthcare Conference (JPM) recently confident they had every chance of perking up investor interest in their story.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription